Pakar Kista

Cyst Health, Explained

Breaking News
• Stryker cuts 2026 forecast amid joint procedure slowdown • Labcorp, Quest Urge RESULTS Act to Prevent Medicare Cuts • FDA clears device to fix leaky heart valves • Boston Scientific slashes 2026 guidance third time • MedTech Leaders Warn AI Adoption Is Complex

Hot Stories

MedTech CEOs Discuss Cyber Threats, Cost Pressures
Ovarian Health

MedTech CEOs Discuss Cyber Threats, Cost Pressures

MedTech CEOs in Boston discuss cybersecurity threats and cost pressures at AdvaMed conference, sharing strategies for navigating market challenges in the medica

By Trisna Anggraini Oct 27, 2026

Cyst Risks

View All

Cyst Types

FDA clears device to fix leaky heart valves
Cyst Types

FDA clears device to fix leaky heart valves

The FDA clears a device to fix leaky heart valves, treating paravalvular leak after valve replacement surgery.

By Salsabila Hartanti Oct 30, 2026

Diagnosis Guides

View All
Boston Scientific slashes 2026 guidance third time

Boston Scientific slashes 2026 guidance third time

Oct 29, 2026
MedTech Leaders Warn AI Adoption Is Complex

MedTech Leaders Warn AI Adoption Is Complex

Oct 28, 2026
FDA clears Edwards tricuspid valve repair device

FDA clears Edwards tricuspid valve repair device

Oct 26, 2026
Elevance Requires Hospitals to Specify Care Location

Elevance Requires Hospitals to Specify Care Location

Oct 7, 2026

Ovarian Health

All Stories

Treatment Options

All Stories

All Post

Stryker cuts 2026 forecast amid joint procedure slowdown

Stryker cuts 2026 forecast amid joint procedure slowdown

By Aurel Maulana November 1, 2026
Stryker has lowered its sales guidance for 2026 after reporting a slowdown in joint replacement procedures. The company now expects sales growth of 6.5%.
Labcorp, Quest Urge RESULTS Act to Prevent Medicare Cuts

Labcorp, Quest Urge RESULTS Act to Prevent Medicare Cuts

By Trisna Anggraini October 31, 2026
Labcorp and Quest Diagnostics urge Congress to pass the RESULTS Act by year-end to prevent Medicare and Medicaid reimbursement cuts beginning in 2027, highlight
FDA clears device to fix leaky heart valves

FDA clears device to fix leaky heart valves

By Salsabila Hartanti October 30, 2026
The FDA clears a device to fix leaky heart valves, treating paravalvular leak after valve replacement surgery.
Boston Scientific slashes 2026 guidance third time

Boston Scientific slashes 2026 guidance third time

By Trisna Anggraini October 29, 2026
Boston Scientific slashes 2026 earnings and sales guidance for the third consecutive time due to a cyberattack and product line challenges, lowering revenue gro
MedTech Leaders Warn AI Adoption Is Complex

MedTech Leaders Warn AI Adoption Is Complex

By Aurel Maulana October 28, 2026
AI adoption in medtech is more complicated than many expect, with leaders at AdvaMed’s conference warning that deployments are far fewer than hype suggests.
MedTech CEOs Discuss Cyber Threats, Cost Pressures

MedTech CEOs Discuss Cyber Threats, Cost Pressures

By Trisna Anggraini October 27, 2026
MedTech CEOs in Boston discuss cybersecurity threats and cost pressures at AdvaMed conference, sharing strategies for navigating market challenges in the medica
FDA clears Edwards tricuspid valve repair device

FDA clears Edwards tricuspid valve repair device

By Trisna Anggraini October 26, 2026
Edwards Lifesciences receives FDA clearance for tricuspid valve repair device to treat severe symptomatic tricuspid regurgitation.
FDA expands import block on Olympus endoscopes

FDA expands import block on Olympus endoscopes

By Salsabila Hartanti October 25, 2026
FDA expands import block, halting shipment of five Olympus endoscopes made in Japan after a June 2025 alert barred 58 devices over patient safety concerns.
Health providers shift AI device liability

Health providers shift AI device liability

By Aurel Maulana October 24, 2026
Health providers argue developers should be accountable for safety of medical devices using generative artificial intelligence, not them, in recent comments to
Labcorp acquires Myriad prenatal testing unit for $210M

Labcorp acquires Myriad prenatal testing unit for $210M

By Salsabila Hartanti October 23, 2026
Labcorp Myriad prenatal testing acquisition for $210M expands diagnostic capabilities with four key tests projected to generate $160M annually.
1 2 3 … 15
© 2026 Pakar Kista. All rights reserved.